Cysteinyl-leukotriene receptor antagonist montelukast decreases blood–brain barrier permeability but does not prevent oedema formation in traumatic brain injury

References

• Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philosophical Transactions of the Royal Society B: Biological Sciences 2003; 358: 1669–1677
   PubMed Web of Science ®Google Scholar
• Hausmann R, Biermann T, Wiest I, Tübel J, Betz P. Neuronal apoptosis following human brain injury. International Journal of Legal Medicine 2004; 118: 32–36
   PubMed Web of Science ®Google Scholar
• Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury 2007; 38: 1392–1400
   PubMed Web of Science ®Google Scholar
• Kelley BJ, Lifshitz J, Povlishock JT. Neuroinflammatory responses after experimental diffuse traumatic brain injury. Journal of Neuropathology and Experimental Neurology 2007; 66: 989–1001
   PubMed Web of Science ®Google Scholar
• Capra V, Ambrosio M, Riccioni G, Rovati GE. Cysteinyl-leukotriene receptor antagonists: Present situation and future opportunities. Current Medicinal Chemistry 2006; 13: 3213–3226
   PubMed Web of Science ®Google Scholar
• Sala A, Folco G. Neutrophils, endothelial cells, and cysteinyl leukotrienes: A new approach to neutrophil-dependent inflammation?. Biochemical and Biophysical Research Communications 2001; 283: 1003–1006
   PubMed Web of Science ®Google Scholar
• Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. British Journal of Pharmacology 2006; 147: S232–S240
   PubMed Web of Science ®Google Scholar
• Moos MP, Mewburn JD, Kan FW, Ishii S, Abe M, Sakimura K, Noguchi K, Shimizu T, Funk CD. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport. FASEB Journal 2008, doi: 10.1096/fj.08-113274
   PubMed Web of Science ®Google Scholar
• Rovati GE, Capra V. Cysteinyl-leukotriene receptors and cellular signals. The Scientific World Journal 2007; 7: 1375–1392
   Web of Science ®Google Scholar
• Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO Journal 2006; 25: 4615–4627
   PubMed Web of Science ®Google Scholar
• Zhang WP, Hu H, Zhang L, Ding W, Yao HT, Chen KD, Sheng WW, Chen Z, Wei EQ. Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neuroscience Letters 2004; 363: 247–251
   PubMed Web of Science ®Google Scholar
• Hu H, Chen G, Zhang JM, Zhang WP, Zhang L, Ge QF, Yao HT, Ding W, Chen Z, Wei EQ. Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors. Acta Pharmacologica Sinica 2005; 26: 685–690
   PubMed Web of Science ®Google Scholar
• Di Gennaro A, Carnini C, Buccellati C, Ballerio R, Zarini S, Fumagalli F, Viappiani S, Librizzi L, Hernandez A, Murphy RC, et al. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: A role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB Journal 2004; 18: 842–844
   PubMed Web of Science ®Google Scholar
• Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. Journal of Neurosurgery 1994; 80: 291–300
   PubMed Web of Science ®Google Scholar
• Ucar T, Tanriover G, Gurer I, Onal MZ, Kazan S. Modified experimental mild traumatic brain injury model. Journal of Trauma 2006; 60: 558–565
   PubMedGoogle Scholar
• Toklu HZ, Keyer Uysal M, Kabasakal L, et al. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. Journal of Surgical Research 2009; 152: 238–248
   PubMed Web of Science ®Google Scholar
• Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods in Enzymology 1978; 53: 302–311
   Google Scholar
• Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine 1963; 61: 882–888
   PubMed Web of Science ®Google Scholar
• Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. Journal of Pharmacological Methods 1990; 24: 285–295
   PubMedGoogle Scholar
• Reading HW, Isbir T. The role of cation activated ATPase in transmitter release from the rat iris. Quarterly Journal of Experimental Physiology 1980; 65: 105–116
   PubMed Web of Science ®Google Scholar
• Fiske CH, SubbaRow Y. The colorimetric determination of phosphorus. Journal of Biological Chemistry 1925; 66: 375–400
   Google Scholar
• Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Bäck M. Leukotriene receptors: Crucial components in vascular inflammation. The ScientificWorld Journal 2007; 7: 1422–1439
   PubMed Web of Science ®Google Scholar
• Ansari MA, Roberts KN, Scheff SW. Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radical Biology & Medicine 2008; 45: 443–452
   PubMed Web of Science ®Google Scholar
• Sener G, Sehirli O, Velioglu-Ogunc A, Cetinel S, Gedik N, Caner M, Sakarcan A, Yegen BC. Montelukast protects against renal ischemia/reperfusion injury in rats. Pharmacological Research 2006; 54: 65–71
   PubMed Web of Science ®Google Scholar
• Sener G, Sehirli O, Toklu H, Ercan F, Alican I. Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat. Journal of Pharmacy and Pharmacology 2007; 59: 837–842
   PubMed Web of Science ®Google Scholar
• Werner C, Engelhard K. Pathophysiology of traumatic brain injury. British Journal of Anaesthesia 2006; 99: 4–9
   Web of Science ®Google Scholar
• Lima FD, Souza MA, Furian AF, Rambo LM, Ribeiro LR, Martignoni FV, Hoffmann MS, Fighera MR, Royes LF, Oliveira MS, de Mello CF. Na+,K + -ATPase activity impairment after experimental traumatic brain injury: Relationship to spatial learning deficits and oxidative stress. Behavioural Brain Research 2008; 193: 306–310
   PubMed Web of Science ®Google Scholar
• Ayata C, Ropper AH. Ischaemic brain oedema. Journal of Clinical Neuroscience 2002; 9: 113–124
   PubMed Web of Science ®Google Scholar
• Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience 2004; 129: 1021–1029
   PubMed Web of Science ®Google Scholar
• Park E, Bell JD, Baker AJ. Traumatic brain injury: Can the consequences be stopped?. Canadian Medical Association Journal 2008; 178: 1163–1170
   PubMed Web of Science ®Google Scholar
• Schuhmann MU, Mokhtarzadeh M, Stichtenoth DO, Skardelly M, Klinge PM, Gutzki FM, Samii M, Brinker T. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. Neurological Research 2003; 25: 481–491
   PubMed Web of Science ®Google Scholar
• Zhang LH, Zho JB, Wang YF. Research advance in cysteinyl leukotriene receptors with brain injury. Zhejiang Da Xue Xue Bao Yi Xue Ban 2008; 37: 315–320, [Only the abstract was seen]
   PubMedGoogle Scholar
• Wang ML, Huang XJ, Fang SH, Yuan YM, Zhang WP, Lu YB, Ding Q, Wei EQ. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression. Biochemical and Biophysical Research Communications 2006; 350: 399–404
   PubMed Web of Science ®Google Scholar
• Sheng WW, Li CT, Zhang WP, Yuan YM, Hu H, Fang SH, Zhang L, Wei EQ. Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death. Biochemical and Biophysical Research Communications 2006; 346: 19–25
   PubMed Web of Science ®Google Scholar
• Huang XJ, Zhang WP, Li CT, Shi WZ, Fang SH, Lu YB, Chen Z, Wei EQ. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation. Glia 2008; 56: 27–37
   PubMed Web of Science ®Google Scholar
• Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, Zhang Q, Chen Z, Mei RH, Zhao MH. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 2005; 73: 31–40
   PubMed Web of Science ®Google Scholar
• Genovese T, Rossi A, Mazzon E, Di Pola R, Muià C, Caminiti R, Bramanti P, Sautebin L, Cuzzocrea S. Effects of zileuton and montelukast in mouse experimental spinal cord injury. British Journal of Pharmacology 2008; 153: 568–582
   PubMed Web of Science ®Google Scholar